Cargando…
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19
It is proposed that the beneficial action of mesenchymal stem cells (MSCs) in COVID-19 and other inflammatory diseases could be attributed to their ability to secrete bioactive lipids (BALs) such as prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) and other similar BALs. This implies that MSCs that hav...
Autor principal: | Das, Undurti N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390526/ https://www.ncbi.nlm.nih.gov/pubmed/32765941 http://dx.doi.org/10.14336/AD.2020.0521 |
Ejemplares similares
-
Bioactive Lipids in COVID-19-Further Evidence
por: Das, Undurti N.
Publicado: (2021) -
Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
por: Das, Undurti N.
Publicado: (2020) -
Response to: Bioactive Lipids and Coronavirus (COVID-19)-further Discussion
por: Das, Undurti N.
Publicado: (2020) -
Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
por: Das, Undurti N.
Publicado: (2020) -
Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
por: Das, Undurti N.
Publicado: (2018)